Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lowering lipids after a stroke or transient ischaemic attack.

Harry McNaughton1

  • 1Medical Research Institute of New Zealand, 99 The Terrace, Wellington, New Zealand.

Hospital Medicine (London, England : 1998)
|March 21, 2002
PubMed
Summary

Clinical uncertainty exists regarding aggressive cholesterol management after stroke or transient ischemic attack. This review examines cholesterol

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can administrative data be used for a national register of hospitalised stroke patients? A New Zealand validation study.

The Lancet regional health. Western Pacific·2026
Same author

Low back pain, with or without sciatica.

Practical neurology·2025
Same author

"Taking Charge" after a diagnosis of cognitive impairment or dementia: a randomized controlled trial.

The Gerontologist·2025
Same author

The impact of inpatient and community stroke rehabilitation on health-related quality of life in New Zealand.

European journal of physical and rehabilitation medicine·2025
Same author

Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial.

Stroke·2025
Same author

Take charge after long COVID: a mixed methods randomised controlled pilot study protocol.

Annals of medicine·2025

Area of Science:

  • Neurology
  • Cardiology
  • Clinical Pharmacology

Background:

  • Elevated cholesterol is a known risk factor for cardiovascular events.
  • Clinical management guidelines for cholesterol post-stroke or transient ischemic attack (TIA) lack definitive consensus.
  • Significant uncertainty persists regarding the optimal intensity of lipid-lowering therapy in this patient population.

Purpose of the Study:

  • To review the existing evidence linking cholesterol levels to stroke risk.
  • To evaluate the potential benefits and justification for using lipid-lowering drugs in patients post-stroke or TIA.

Main Methods:

  • Literature review of studies investigating cholesterol levels and stroke.
  • Analysis of clinical trial data on lipid-lowering drug efficacy in secondary stroke prevention.
  • Synthesis of current evidence to address clinical uncertainty.

Main Results:

  • Evidence supports a link between higher cholesterol levels and increased stroke risk.
  • Lipid-lowering therapies have demonstrated efficacy in reducing cardiovascular events, including stroke.
  • The data suggest a potential benefit of aggressive cholesterol management in secondary stroke prevention.

Conclusions:

  • Aggressive cholesterol management following stroke or TIA is likely beneficial.
  • Lipid-lowering drugs are a justifiable treatment option for patients at risk of recurrent stroke.
  • Further research may refine treatment thresholds and drug choices.

Related Experiment Videos